Skip to main content
Certara, Inc. (CERT)
NASDAQ: CERT · IEX Real-Time Price · USD
16.08
-0.39 (-2.37%)
At close: May 17, 2024, 4:00 PM
15.73
-0.35 (-2.18%)
After-hours: May 17, 2024, 6:30 PM EDT

Certara Revenue

Certara had revenue of $360.69M in the twelve months ending March 31, 2024, with 4.73% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $96.65M with 7.04% year-over-year growth. In the year 2023, Certara had annual revenue of $354.34M with 5.57% growth.

Revenue (ttm)
$360.69M
Revenue Growth
+4.73%
P/S Ratio
7.13
Revenue / Employee
$259,303
Employees
1,391
Market Cap
2.57B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023354.34M18.69M5.57%
Dec 31, 2022335.64M49.54M17.32%
Dec 31, 2021286.10M42.57M17.48%
Dec 31, 2020243.53M35.02M16.79%
Dec 31, 2019208.51M44.79M27.36%
Dec 31, 2018163.72M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
Evolent Health 2.18B
Progyny 1.11B
PTC Therapeutics 927.56M
Inari Medical 520.66M
TG Therapeutics 289.33M
Twist Bioscience 277.49M
Immunocore Holdings 264.25M
Revenue Rankings

CERT News

More News